ArticleCurrent oncology (Toronto, Ont.)2025

Pan-Immune-Inflammation Value as a Predictor of Long-Term Outcomes in Patients with Urothelial Carcinoma of the Bladder: A Pilot Study.

Ali Erhan Eren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.